Marc‐Henri Stern
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Ophthalmology top 0.5%
- Ocular Oncology and Treatments
Papers in
-
- DNA Repair Mechanisms 20
- Ubiquitin and proteasome pathways 10
-
- Cancer Genomics and Diagnostics 35
- Co-authors
- Anne Vincent‐Salomon (30 shared papers)Tatiana Popova (26 shared papers)Dominique Stoppa‐Lyonnet (25 shared papers)François‐Clément Bidard (22 shared papers)Élodie Manié (14 shared papers)Xavier Sastre‐Garau (11 shared papers)Jean‐Yves Pierga (21 shared papers)Olivier Delattre (9 shared papers)
- Journals
- Blood (14 papers)Cancer Research (9 papers)Cancers (7 papers)Nature Communications (4 papers)Oncogene (4 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Marc‐Henri Stern
143 papers receiving 6.5k citations
Marc‐Henri Stern's Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 1.8k
- Ophthalmology 912
- Oncology 2.0k
- Genetics 593
- Immunology 1.0k
Countries citing papers authored by Marc‐Henri Stern
This map shows the geographic impact of Marc‐Henri Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc‐Henri Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc‐Henri Stern more than expected).
Fields of papers citing papers by Marc‐Henri Stern
This network shows the impact of papers produced by Marc‐Henri Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc‐Henri Stern. The network helps show where Marc‐Henri Stern may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc‐Henri Stern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Uveal melanoma Hit paper breakdown → | 2020 | 519 |
| 2 | 2012 | 424 | |
| 3 | SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma Hit paper breakdown → | 2013 | 323 |
| 4 | 2016 | 276 | |
| 5 | 2010 | 260 | |
| 6 | 2014 | 216 | |
| 7 | 2018 | 210 | |
| 8 | 2008 | 170 | |
| 9 | 2017 | 162 | |
| 10 | 2007 | 155 | |
| 11 | 2018 | 152 | |
| 12 | 2013 | 148 | |
| 13 | 1998 | 133 | |
| 14 | MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. | 1993 | 121 |
| 15 | 2009 | 119 | |
| 16 | 2009 | 113 | |
| 17 | 1990 | 112 | |
| 18 | 1998 | 105 | |
| 19 | 2015 | 93 | |
| 20 | 2016 | 82 |
About Marc‐Henri Stern
Marc‐Henri Stern is a scholar working on Molecular Biology, Cancer Research, Oncology, Ophthalmology and Immunology, having authored 144 papers that have together received 6.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (35 papers), Ocular Oncology and Treatments (27 papers), DNA Repair Mechanisms (20 papers), Chronic Lymphocytic Leukemia Research (16 papers), BRCA gene mutations in cancer (14 papers), T-cell and Retrovirus Studies (11 papers), Genetic factors in colorectal cancer (11 papers) and Ubiquitin and proteasome pathways (10 papers). The work is most often cited by research in Cancer Research (1.8k citations), Ophthalmology (912 citations), Oncology (2.0k citations), Genetics (593 citations) and Immunology (1.0k citations). Marc‐Henri Stern has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Anne Vincent‐Salomon, Tatiana Popova, Dominique Stoppa‐Lyonnet, François‐Clément Bidard, Élodie Manié, Xavier Sastre‐Garau, Jean‐Yves Pierga, Olivier Delattre, Jean Soulier and Sophie Piperno‐Neumann. Their work appears in journals such as Blood, Cancer Research, Cancers, Nature Communications and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.